Laura Chico

Stock Analyst at Wedbush

(3.63)
# 828
Out of 5,024 analysts
224
Total ratings
44.81%
Success rate
8.11%
Average return

Stocks Rated by Laura Chico

Larimar Therapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $15$11
Current: $4.12
Upside: +166.99%
PepGen
Sep 30, 2025
Maintains: Outperform
Price Target: $9$8
Current: $4.67
Upside: +71.31%
Dianthus Therapeutics
Sep 12, 2025
Maintains: Outperform
Price Target: $42$44
Current: $35.48
Upside: +24.01%
Tourmaline Bio
Sep 9, 2025
Downgrades: Neutral
Price Target: $48
Current: $47.91
Upside: +0.19%
Jade Biosciences
Aug 14, 2025
Maintains: Outperform
Price Target: $17$18
Current: $9.38
Upside: +91.98%
Solid Biosciences
Aug 13, 2025
Maintains: Outperform
Price Target: $17$14
Current: $6.19
Upside: +126.17%
Stoke Therapeutics
Aug 13, 2025
Maintains: Outperform
Price Target: $16$22
Current: $36.12
Upside: -39.09%
Xenon Pharmaceuticals
Aug 12, 2025
Maintains: Outperform
Price Target: $42$43
Current: $41.10
Upside: +4.62%
Travere Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $30$32
Current: $26.35
Upside: +21.44%
Gossamer Bio
Aug 6, 2025
Maintains: Outperform
Price Target: $4$5
Current: $2.40
Upside: +108.33%
Maintains: Outperform
Price Target: $13$14
Current: $5.04
Upside: +177.78%
Maintains: Outperform
Price Target: $137$141
Current: $138.32
Upside: +1.94%
Maintains: Neutral
Price Target: $35$34
Current: $32.52
Upside: +4.55%
Initiates: Outperform
Price Target: $17
Current: $28.67
Upside: -40.70%
Maintains: Outperform
Price Target: $16$18
Current: $6.66
Upside: +170.47%
Reiterates: Neutral
Price Target: $130
Current: $122.58
Upside: +6.05%
Reiterates: Neutral
Price Target: $121
Current: $143.52
Upside: -15.69%
Reiterates: Outperform
Price Target: $27
Current: $21.87
Upside: +23.46%
Reiterates: Neutral
Price Target: $4
Current: $5.64
Upside: -29.10%
Maintains: Outperform
Price Target: $32$30
Current: $16.08
Upside: +86.57%
Maintains: Neutral
Price Target: $34$26
Current: $30.80
Upside: -15.58%
Maintains: Underperform
Price Target: $26$28
Current: $54.75
Upside: -48.86%
Maintains: Outperform
Price Target: $43
Current: $15.02
Upside: +186.28%
Maintains: Outperform
Price Target: $4$3
Current: $1.70
Upside: +76.47%
Maintains: Outperform
Price Target: $27$28
Current: $11.88
Upside: +135.69%
Maintains: Neutral
Price Target: $30$29
Current: $24.83
Upside: +16.79%
Maintains: Neutral
Price Target: $8$7
Current: $5.21
Upside: +34.36%
Reiterates: Outperform
Price Target: $42
Current: $21.73
Upside: +93.28%
Maintains: Outperform
Price Target: $13$11
Current: $0.56
Upside: +1,864.29%
Reiterates: Neutral
Price Target: $5
Current: $7.01
Upside: -28.67%
Initiates: Market Perform
Price Target: n/a
Current: $53.00
Upside: -
Maintains: Outperform
Price Target: $9$5
Current: $5.28
Upside: -5.30%
Downgrades: Neutral
Price Target: $149
Current: $17.35
Upside: +755.91%
Initiates: Outperform
Price Target: $720
Current: $16.71
Upside: +4,210.09%
Initiates: Strong Buy
Price Target: $280
Current: $108.01
Upside: +159.24%